Skip to contentE
Escalon Medical Corp
E
ESMCEscalon Medical Corp Q1 2026 · 10-Q
Revenue$2.68M$2.68M−3.8% vs Q1 2025 Net Income-$239.85K-$239.85KN/M vs Q1 2025 EPS Diluted-$0.03-$0.03N/M vs Q1 2025 Operating Income-$202,751N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Escalon Medical Corp · CIK 862668 · Engraved from SEC EDGAR
Free Cash Flowderived$80,587+141.8% Margins · derivedOperating margin-7.6%−6.6 pt vs Q1 2025
Net margin-9.0%−7.8 pt vs Q1 2025
ended Sep 30, 2025 · filed Nov 14, 2025 · 45 d after period end